Identifying authentic J&J Innovative Medicine HIV medicines
Patients, healthcare providers and pharmacists can identify authentic HIV medicines versus a counterfeit form by looking at the tablet. Janssen HIV medicine tablet descriptions are listed below for SYMTUZA® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide), PREZCOBIX® (darunavir/cobicistat), PREZISTA® (darunavir), EDURANT® (rilpivirine) and INTELENCE® (etravirine).
Product and important safety information for these medicines can be found on the individual brand websites.
(Pills Are Not Actual Size)
What should I do if I suspect counterfeit HIV medicine?
If tablets in any bottle of medicine do not match the description of the prescribed product, or if the packaging, labeling or inserts accompanying the bottle appear to adulterated, false or altered this should be reported immediately to the FDA’s Office of Criminal Investigations (OCI) at 1-800-551-3989 ( http://www.fda.gov/OCI) or Janssen Medical Information at 1-800-JANSSEN (1-800-526-7736), or [email protected], or at https://AskJanssenMedicalInformation.com. If patients identify counterfeit product, they should not take the suspect medicine and should contact their prescriber immediately to ensure they can access authentic HIV medication and adequately continue antiretroviral treatment.
If a patient is experiencing any adverse effects related to Janssen medicines or to the use of counterfeit medicines, they should immediately contact FDA’s MedWatch Program (1-800-FDA-1088) or Janssen Medical Information at 1-800-JANSSEN (1-800-526-7736), or [email protected], or at https://AskJanssenMedicalInformation.com.